A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients - Trial NCT06021041
Access comprehensive clinical trial information for NCT06021041 through Pure Global AI's free database. This phase not specified trial is sponsored by Tongji Hospital and is currently Recruitment Completed. The study focuses on Tuberculosis. Target enrollment is 900 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Tongji Hospital
Timeline & Enrollment
N/A
Jan 13, 2018
Feb 01, 2024
Primary Outcome
2-year survival rate,2-year disability rate
Summary
This is a retrospective clinical study to analyze the clinical characteristics,
 complications, and effects of different treatment options on long-term prognosis of severe
 tuberculosis patients. All cases of severe tuberculosis diagnosed between 2016 and 2021 were
 included in the electronic medical record system of one center, and data such as
 demographics, hospitalization information, clinical information, laboratory or imaging
 examinations, treatment plans, and outcomes were collected.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06021041
Non-Device Trial